Creating Hope Reauthorization Act of 2024
Official title: To amend the Federal Food, Drug, and Cosmetic Act to extend the authority of the Secretary of Health and Human Services to issue priority review vouchers to en… Show full official titleShow less
Official title: To amend the Federal Food, Drug, and Cosmetic Act to extend the authority of the Secretary of Health and Human Services to issue priority review vouchers to encourage treatments for rare pediatric diseases.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the Subcommittee on Health.
Creating Hope Reauthorization Act of 2024
This bill extends until FY2029 a Food and Drug Administration program that awards priority review vouchers to manufacturers of drugs that treat rare pediatric diseases. (A priority review voucher entitles the voucher holder to priority review of a single human drug application.)
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 7384: Creating Hope Reauthorization Act of 2024. 118th Congress. Open America. https://openamerica.io/bill/118-HR-7384/
"H.R. 7384: Creating Hope Reauthorization Act of 2024." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-7384/.
H.R. 7384, 118th Cong. (2026), https://openamerica.io/bill/118-HR-7384/.
[H.R. 7384: Creating Hope Reauthorization Act of 2024](https://openamerica.io/bill/118-HR-7384/)